Healthcare
Healthcare is undergoing a structural transformation driven by data, computation and biology
The convergence of multi omic analysis, advanced imaging, bio sample intelligence, AI driven diagnostics, longevity science and personalized therapeutics is redefining how health is measured, predicted and optimized. We focus on the founders building the systems, platforms and technologies that will shape the next era of human health.
Our Thesis
We focus on technologies that shift healthcare from reactive to predictive, preventive and personalized. The next decade of value creation will come from platforms that can sense, analyze and act on biological information in real time at scale.
This includes:
• Multi omic platforms (genomics, proteomics, metabolomics, epigenomics)
• AI native diagnostics and autonomous clinical decision engines
• Advanced imaging and computational radiology
• Bio sample intelligence and real time biomarker monitoring
• Longevity technologies and cellular rejuvenation
• Precision therapeutics and targeted interventions
• Biohacking, performance and human optimization systems
• Digital health infrastructure and intelligent care delivery
Our Approach
We combine the discipline of Private Equity with the early access advantage of Venture Capital. Our approach is built on three principles:
• Scientific depth: we understand the underlying biology, not just the pitch deck.
• Data driven conviction: we invest where computational and biological curves converge.
• Clinical and operational clarity: we back founders who can navigate regulatory, scientific and market complexity with precision.
We analyze healthcare as a systems problem, not a sector.
Our Focus
We back companies building:
• AI driven diagnostic platforms
• Next generation imaging and sensing technologies
• Longevity and regenerative medicine solutions
• Precision health and personalized therapeutics
• Bio data infrastructure and intelligent care systems
• Digital health platforms with real clinical impact
Our focus is on early stage, rapid growth environments where computation, biology and engineering intersect.
We partner with founders who:
• Operate with scientific rigor and first principles thinking
• Build technologies with clinical relevance and measurable outcomes
• Understand regulatory pathways and market dynamics
• Move fast without compromising safety or quality
• Aim to redefine standards of care, not iterate on them
We are a highly specialized, highly focused firm with more than a decade of experience identifying structural shifts before they become mainstream. Our partners choose us because we combine:
• Deep scientific and technical understanding
• Global perspective on healthcare markets
• Institutional discipline and due diligence rigor
• Early stage access to frontier technologies
• A long term relationship mindset
We treat every founder and every investor as a strategic partner because they are. And we operate with one intention: to identify and support the technologies that will define the future of human health.